Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

NCT: NCT06073457 · ACTIVE_NOT_RECRUITING

NCT IDNCT06073457
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-06
Completion2027-01

Brief Summary

The purpose of this clinical research study is to evaluate the feasibility of the GT Metabolic Solutions Magnet System, GJ Biofragmentable ("MagGJ System") for creation of a side-to-side anastomosis for gastro-ileal or gastro-jejunal diversion in obese adults.

Frequently Asked Questions

What is Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")?

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study") is a clinical trial registered under NCT06073457. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06073457?

The current status of NCT06073457 (Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")) is: ACTIVE_NOT_RECRUITING.

When did Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study") start?

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study") started on 2023-11-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑